Actualités Nanobac Pharmaceuticals Inc (CE) - NNBP | Actions OTCMarkets

Votre Hub pour des idées et discussions en direct en temps réel

- Termination of Registration of a Class of Security under Section 12(g) (15-12G)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF...

Nanobac Pharmaceuticals Inc - Annual Report (Small Business Issuers) (10KSB)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB Annual Report Pursuant to Section 13 or 15(d...

Nanobac Pharmaceuticals Inc - Notification that Annual Report will be submitted late (NT 10-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number 0-24696 NOTIFICATION OF LATE FILING...

Nanobac Pharmaceuticals Inc. Engages Legal Team to Enforce Patent Rights

Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company?) is pleased to announce that it has engaged Guy...

Nanobac Announces European Heart Journal Publication of Association Between Calcifying Nanoparticles and Aortic Stenosis

Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company?) announces the multicenter publication of independent...

Nanobac Announces Baylor College of Medicine Initial Results for Nanoparticle and Gall Stone Formation Study

Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) (?Nanobac? or ?the Company?) announces that scientists at the Baylor College of...

Nanobac Pharmaceuticals Inc - Amended Current report filing (8-K/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________ FORM 8K/A CURRENT REPORT Pursuant to...

Nanobac Pharmaceuticals Inc - Amended Current report filing (8-K/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________ FORM 8K/A CURRENT REPORT Pursuant to...

Nanobac Pharmaceuticals Inc - Amended Quarterly Report of Financial Condition (10QSB/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A QUARTERLY REPORT Pursuant to Section 13...

Nanobac Pharmaceuticals Inc - Quarterly Report of Financial Condition (10QSB)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________ FORM 10-QSB QUARTERLY REPORT...

Nanobac Pharmaceuticals Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number 0-24696 NOTIFICATION OF LATE FILING...

Nanobac Pharmaceuticals Inc - Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8K CURRENT REPORT Pursuant to Section 13...

Nanobac Pharmaceuticals Inc. To Begin Domestic Manufacturing of Diagnostic Tests

Nanobac Pharmaceuticals Inc. (OTCBB:NNBP)?("Nanobac" or "the Company") announces that its proprietary CE marked Nano-Capture...

Nanobac Pharmaceuticals Completes Phase I Scientific Plan

Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company") announces that it has completed Phase I of its 2006...

New Evidence on Calcifying Nanoparticle as a Cause of Chronic Infection, and Potential Danger of Other Nano-Apatite Particles Us

Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company") announces the publication of correspondence in the June...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Nanobac Pharmaceuticals Inc (CE) (NNBP)

Votre Hub pour des idées et discussions en direct en temps réel

NNBP Actualités

- Termination of Registration of a Class of Security under Section 12(g) (15-12G)

Nanobac Pharmaceuticals Inc - Annual Report (Small Business Issuers) (10KSB)

Nanobac Pharmaceuticals Inc - Notification that Annual Report will be submitted late (NT 10-K)

Nanobac Pharmaceuticals Inc. Engages Legal Team to Enforce Patent Rights

Nanobac Announces European Heart Journal Publication of Association Between Calcifying Nanoparticles and Aortic Stenosis

Nanobac Announces Baylor College of Medicine Initial Results for Nanoparticle and Gall Stone Formation Study

Nanobac Pharmaceuticals Inc - Amended Current report filing (8-K/A)

Nanobac Pharmaceuticals Inc - Amended Current report filing (8-K/A)

Nanobac Pharmaceuticals Inc - Amended Quarterly Report of Financial Condition (10QSB/A)

Nanobac Pharmaceuticals Inc - Quarterly Report of Financial Condition (10QSB)

Nanobac Pharmaceuticals Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)

Nanobac Pharmaceuticals Inc - Current report filing (8-K)

Nanobac Pharmaceuticals Inc. To Begin Domestic Manufacturing of Diagnostic Tests

Nanobac Pharmaceuticals Completes Phase I Scientific Plan

New Evidence on Calcifying Nanoparticle as a Cause of Chronic Infection, and Potential Danger of Other Nano-Apatite Particles Us

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Nanobac Pharmaceuticals Inc (CE) (NNBP) Actualités

Nanobac Pharmaceuticals Inc (CE) (NNBP)

Votre Hub pour des idées et discussions en direct en temps réel

NNBP Actualités

- Termination of Registration of a Class of Security under Section 12(g) (15-12G)

Nanobac Pharmaceuticals Inc - Annual Report (Small Business Issuers) (10KSB)

Nanobac Pharmaceuticals Inc - Notification that Annual Report will be submitted late (NT 10-K)

Nanobac Pharmaceuticals Inc. Engages Legal Team to Enforce Patent Rights

Nanobac Announces European Heart Journal Publication of Association Between Calcifying Nanoparticles and Aortic Stenosis

Nanobac Announces Baylor College of Medicine Initial Results for Nanoparticle and Gall Stone Formation Study

Nanobac Pharmaceuticals Inc - Amended Current report filing (8-K/A)

Nanobac Pharmaceuticals Inc - Amended Current report filing (8-K/A)

Nanobac Pharmaceuticals Inc - Amended Quarterly Report of Financial Condition (10QSB/A)

Nanobac Pharmaceuticals Inc - Quarterly Report of Financial Condition (10QSB)

Nanobac Pharmaceuticals Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)

Nanobac Pharmaceuticals Inc - Current report filing (8-K)

Nanobac Pharmaceuticals Inc. To Begin Domestic Manufacturing of Diagnostic Tests

Nanobac Pharmaceuticals Completes Phase I Scientific Plan

New Evidence on Calcifying Nanoparticle as a Cause of Chronic Infection, and Potential Danger of Other Nano-Apatite Particles Us

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités